Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Using the Inverness Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in HIV-Positive TB Suspects in Cape Town, South Africa

NCT01693224 is registered in ClinicalTrials.gov with Tuberculosis Clinical Diagnostics Research Consortium as lead sponsor.

NCT NCT01693224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01693224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Using the Inverness Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in HIV-Positive TB Suspects in Cape Town, South Africa
Lead sponsor
Tuberculosis Clinical Diagnostics Research Consortium
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2011
Completion date
February 28, 2013
Enrollment
512 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, tuberculosis, miliary, tuberculosis, pulmonary